Ha seleccionado la visión en Inglés
Descriptor en español: |
beta-N-Acetilhexosaminidasas
| ||||||
Descriptor en inglés: | beta-N-Acetylhexosaminidases | ||||||
Descriptor en portugués: | beta-N-Acetil-Hexosaminidases | ||||||
Descriptor en francés: | beta-N-Acetylhexosaminidases | ||||||
Término(s) alternativo(s): |
N Acetyl beta D hexosaminidase N-Acetyl-beta-D-hexosaminidase beta Hexosaminidase beta N Acetyl D hexosaminidase beta N Acetyl hexosaminidase beta N Acetylhexosaminidase beta N Acetylhexosaminidases beta-Hexosaminidase beta-N-Acetyl-D-hexosaminidase beta-N-Acetyl-hexosaminidase beta-N-Acetylhexosaminidase |
||||||
Código(s) jeráquico(s): |
D08.811.277.450.483.180 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D001619 | ||||||
Nota de alcance: | A hexosaminidase specific for non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Two specific mammalian isoenzymes of beta-N-acetylhexoaminidase are referred to as HEXOSAMINIDASE A and HEXOSAMINIDASE B. Deficiency of the type A isoenzyme causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease. |
||||||
Nota de indización: | do not confuse with ACETYLGLUCOSAMINIDASE; /defic: consider also TAY SACHS DISEASE and SANDHOFF DISEASE |
||||||
Calificadores permitidos: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Número de registro: | EC 3.2.1.52 | ||||||
Nombre CAS Tipo 1: | beta-N-Acetyl-D-hexosaminide N-acetylhexosaminohydrolase | ||||||
Indexación anterior: |
Glycoside Hydrolases (1966-1970) Hexosaminidases (1971-1986) |
||||||
Nota Pública de MeSH: | 2008; see BETA-N-ACETYL-D-HEXOSAMINIDASE 1988-2007 |
||||||
Nota de historia: | 2008(1988) |
||||||
Vea también los descriptores: |
Sandhoff Disease
MeSH Tay-Sachs Disease MeSH | ||||||
Identificador de DeCS: | 19087 | ||||||
ID del Descriptor: | D001619 | ||||||
Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||||
Fecha de establecimiento: | 01/01/1987 | ||||||
Fecha de entrada: | 02/06/1986 | ||||||
Fecha de revisión: | 09/07/2007 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes
|
beta-N-Acetylhexosaminidases
- Concepto preferido
UI del concepto |
M0002423 |
Nota de alcance | A hexosaminidase specific for non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Two specific mammalian isoenzymes of beta-N-acetylhexoaminidase are referred to as HEXOSAMINIDASE A and HEXOSAMINIDASE B. Deficiency of the type A isoenzyme causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease. |
Término preferido | beta-N-Acetylhexosaminidases |
Término(s) alternativo(s) |
N Acetyl beta D hexosaminidase N-Acetyl-beta-D-hexosaminidase beta Hexosaminidase beta N Acetyl D hexosaminidase beta N Acetyl hexosaminidase beta N Acetylhexosaminidase beta N Acetylhexosaminidases beta-Hexosaminidase beta-N-Acetyl-D-hexosaminidase beta-N-Acetyl-hexosaminidase beta-N-Acetylhexosaminidase |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta